TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

LOG IN / REGISTER

LOG IN

Don’t have an account? Register here Give your organization full access to The Jakarta Post. Register here

pfizer

Pfizer-BioNTech's Covid-flu jab disappoints in trial

Science & Tech 1 year ago

Pfizer-BioNTech's Covid-flu jab disappoints in trial

The messenger RNA method made its debut with the Pfizer-BioNTech coronavirus vaccine, which was the first jab against Covid to be approved in the West in late 2020

Three RI biotech lecturers visit Pfizer factory in Belgium, learn global best practices

Front Row 2 years ago

Three RI biotech lecturers visit Pfizer factory in Belgium, learn global best practices

Three selected Indonesian lecturers who participated in capacity-building program HigherHeight – Pfizer Biotech Fellowship 2022 visited a Pfizer manufacturing facility in Puurs-Sint-Amands, Belgium, in April, to enhance participants’ medical biotechnology knowledge as well as give them insight into Pfizer’s manufacturing practices and global supply chain.

Vaccines business potential in a post-COVID world

Academia 3 years ago

Vaccines business potential in a post-COVID world

Increased awareness among patients for vaccine adoption post-pandemic has made pharmaceutical companies invest time, money, and resources in the vaccine business.

Build up equitable vaccination practices before the next pandemic

Academia 3 years ago

Build up equitable vaccination practices before the next pandemic

We cannot afford a repeat of trade barriers stopping the lion’s share of vaccines produced in India from reaching Africans.

US regulators OK use of COVID vaccines in kids as young as 6 months

Americas 3 years ago

US regulators OK use of COVID vaccines in kids as young as 6 months

"We are the first country to protect our youngest children with COVID-19 vaccines," President Joe Biden said in a statement, emphasizing the effectiveness and safety of the inoculations.

Administer any booster available to avoid hospitalization, deaths

Academia 3 years ago

PREMIUM
Administer any booster available to avoid hospitalization, deaths

The effectiveness of COVID-19 vaccination typically decreases within six months of the administration of the second dose.

Obesity may weaken vaccine protection: study

Health 3 years ago

Obesity may weaken vaccine protection: study

Among those in the study without previous SARS-CoV-2 infection who had received the Pfizer vaccine, patients with severe obesity had antibody levels more than three times lower than normal-weight individuals.

Pfizer Q1 revenues jump 77% to $25.7 billion on COVID-19 vaccine

Companies 3 years ago

Pfizer Q1 revenues jump 77% to $25.7 billion on COVID-19 vaccine

The major American drugmaker reported revenues of $25.7 billion for the first quarter, up 77 percent from the year-ago period, with the COVID vaccine taking in $13.2 billion.

Taiwan orders Pfizer's COVID-19 pill as infections rise

Asia & Pacific 3 years ago

Taiwan orders Pfizer's COVID-19 pill as infections rise

Taiwan has kept the pandemic well under control thanks to strict and early control measures. But daily infections have been rising in recent weeks, with 439 new cases reported on Monday, the second-highest daily increase this year.

Indonesia seeks longer shelf life donations as 19 million COVID shots expired

Society 3 years ago

Indonesia seeks longer shelf life donations as 19 million COVID shots expired

Indonesia and many other developing nations are ramping up their vaccination campaign, aided by donations from wealthy countries, but they have been calling for donations with a longer shelf life.

The Jakarta Post - Premium Subscription Banner

follow our Social media

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Let us know what you think:

Enter at least 30 characters

0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.